Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The DEAD box polypeptide 60 pseudogene (ENSG00000224436) is a non-functional genomic sequence that shares homology with the DEAD box RNA helicase family, specifically DDX60. DEAD box proteins are essential regulators of RNA metabolism and act as RNA helicases, but pseudogenes do not produce active protein. Pseudogenes are frequently found throughout the human genome and may occasionally be transcribed into RNA, but they lack evidence for direct involvement in cellular signaling, disease mechanisms, or drug interactions[2][4]. The most relevant DEAD box protein, DDX60, is an antiviral factor and nucleic acid sensor, but the pseudogene variant (DDX60P) is not considered a therapeutic target[5][7]. Some transcribed pseudogenes have been implicated in cancer diagnosis and prognosis, potentially serving as biomarkers for specific malignancies, but there is no strong evidence for clinical or functional relevance of this specific pseudogene[2][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DEAD box polypeptide 60 pseudogene (DDX60P).